Total Payments
$1,910
2024 Payments
$44.36
Companies
19
Transactions
96
Medicare Patients
482
Medicare Billing
$43,488
Payment Breakdown by Category
Food & Beverage$1,910 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,910 | 96 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $503.62 | 8 | $0 (2018) |
| Novo Nordisk Inc | $366.39 | 30 | $0 (2020) |
| Lilly USA, LLC | $234.32 | 9 | $0 (2022) |
| PFIZER INC. | $152.31 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $109.06 | 7 | $0 (2022) |
| GlaxoSmithKline, LLC. | $103.54 | 7 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $93.98 | 5 | $0 (2022) |
| Allergan Inc. | $70.77 | 4 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $58.39 | 3 | $0 (2021) |
| Amarin Pharma Inc. | $53.17 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44.36 | 2 | Exact Sciences Corporation ($30.57) |
| 2022 | $64.14 | 4 | AstraZeneca Pharmaceuticals LP ($31.61) |
| 2021 | $254.26 | 14 | PFIZER INC. ($65.49) |
| 2020 | $334.69 | 20 | Novo Nordisk Inc ($78.15) |
| 2019 | $374.31 | 31 | Novo Nordisk Inc ($212.28) |
| 2018 | $216.44 | 7 | SANOFI-AVENTIS U.S. LLC ($176.55) |
| 2017 | $621.40 | 18 | SANOFI-AVENTIS U.S. LLC ($327.07) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: Oncology | ||||||
| 04/23/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Diabetes | ||||||
| 04/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/07/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: VACCINES | ||||||
| 12/01/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardio-renal | ||||||
| 09/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/31/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Cardio-renal | ||||||
| 08/10/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/05/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Cardio-renal | ||||||
| 07/23/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/16/2021 | Lilly USA, LLC | EMGALITY (Drug), TRULICITY | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Neuroscience | ||||||
| 03/17/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/24/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/12/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/11/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Diabetes | ||||||
| 12/15/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Cardiovascular | ||||||
| 11/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/04/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 90 | 130 | $24,425 | $9,511 |
| 2022 | 5 | 129 | 172 | $26,618 | $10,551 |
| 2021 | 8 | 175 | 229 | $27,904 | $13,203 |
| 2020 | 4 | 88 | 130 | $23,913 | $10,223 |
Total Patients
482
Total Services
661
Medicare Billing
$43,488
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 82 | $18,058 | $6,303 | 34.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $3,150 | $1,760 | 55.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 19 | $3,032 | $1,337 | 44.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 15 | $185.00 | $112.00 | 60.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 80 | $17,540 | $6,018 | 34.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $4,275 | $2,432 | 56.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 20 | $3,160 | $1,150 | 36.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 27 | 27 | $837.00 | $479.34 | 57.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 26 | 26 | $806.00 | $471.16 | 58.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 83 | $15,477 | $6,831 | 44.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 11 | 11 | $3,245 | $1,837 | 56.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 34 | $4,317 | $1,653 | 38.3% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 13 | 14 | $1,400 | $930.02 | 66.4% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 20 | 20 | $1,207 | $754.80 | 62.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 39 | 39 | $1,209 | $711.75 | 58.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 14 | 15 | $645.00 | $248.85 | 38.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 13 | 13 | $403.50 | $237.25 | 58.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 83 | $15,438 | $5,721 | 37.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 21 | 21 | $6,195 | $3,564 | 57.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 14 | $1,764 | $738.88 | 41.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 12 | 12 | $516.00 | $198.18 | 38.4% |
About Dr. Jessica Maisonave, MD
Dr. Jessica Maisonave, MD is a General Practice healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194793927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jessica Maisonave, MD has received a total of $1,910 in payments from pharmaceutical and medical device companies, with $44.36 received in 2024. These payments were reported across 96 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,910).
As a Medicare-enrolled provider, Maisonave has provided services to 482 Medicare beneficiaries, totaling 661 services with total Medicare billing of $43,488. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Other Specialties General Practice
- Location Clermont, FL
- Active Since 03/09/2006
- Last Updated 11/24/2025
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1194793927
Products in Payments
- SOLIQUA (Drug) $393.99
- TRULICITY (Drug) $191.05
- Tresiba (Drug) $151.26
- Ozempic (Drug) $140.63
- TOUJEO (Drug) $109.63
- FARXIGA (Drug) $95.32
- XARELTO (Drug) $93.98
- ELIQUIS (Drug) $77.47
- Victoza (Drug) $62.36
- CHANTIX (Drug) $62.31
- TRELEGY ELLIPTA (Drug) $60.01
- Kerendia (Drug) $58.39
- Vascepa (Drug) $53.17
- NEXLETOL (Drug) $48.48
- Cologuard Collection Kit (Device) $30.57
- LINZESS (Drug) $28.70
- BREO (Drug) $28.34
- BASAGLAR (Drug) $27.70
- NAMZARIC (Drug) $22.20
- VIBERZI (Drug) $19.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Clermont
Fadi Rahhal, Md, MD
General Practice — Payments: $11,386
General Practice $11,386
Egle Skruodyte, Dmd, DMD
General Practice — Payments: $6,308
General Practice $6,308
Dr. Edwin Acosta, Dds, DDS
General Practice — Payments: $6,063
General Practice $6,063
Dr. Carlos Ortiz, D.d.s, D.D.S
General Practice — Payments: $3,626
General Practice $3,626
Nanette Ortiz, Md, MD
General Practice — Payments: $2,828
General Practice $2,828
Dr. Freddy Mezquia, Dmd, DMD
General Practice — Payments: $2,632
General Practice $2,632